NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Latest News & Postscripts

MHRA Updates May & June 2017

Posted: July 10, 2017.
Category - Medicines Update
Tagged with - MHRA Drug Safety Update

Drug Safety Update (June 2017) includes: Denosumab (Prolia, Xgeva ▼): reports of osteone...

Read More...

Medicines Update Primary Care July 2017

Posted: July 06, 2017.
Category - Medicines Update Primary Care
Tagged with - Dietetics Shortages ScriptSwitch

To view this bulletin in PDF format please click here

This bulletin contains information on:

  • High Cost Drugs in Cystic Fibrosis
  • Ensure Shake®
  • Advantages of Olive Oil Ear Drops
  • Launch of Ralvo® 700mg (5%w/w) Medicated Plaster
  • Drug Shortages
  • ScriptSwitch Update: ScriptSwitch Feedback Function

Read More...

New Inhaler Identification Guide

Posted: July 03, 2017.
Category - Medicines Update Acute

The ‘Respiratory Inhalers – Identification Guide’ has been updated to include a number of new inhaler devices. Hard copies will be sent to wards across NHSGGC over the coming weeks.

Read More...

New lipid lowering medicines: Alirocumab and evolocumab

Posted: July 03, 2017.
Category - Medicines Update
Tagged with - Formulary

Two new lipid lowering medicines, alirocumab and evolocumab (PCSK9 inhibitors) are on the GGC Formulary for initiation by specialist lipid clinics. Use is restrict...

Read More...

Formulary Update (June 2017)

Posted: June 26, 2017.
Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.

Read More...

Alogliptin: DPP-4 Inhibitor of Choice

Posted: June 23, 2017.
Category - Medicines Update
Tagged with - Diabetes

The position of alogliptin in the NHSGGC Formulary has changed.  The previous prescribing restriction limiting use in dual therapy has been remov...

Read More...

Fast acting insulin aspart

Posted: June 23, 2017.
Category - Medicines Update
Tagged with - Diabetes

Fast acting Insulin aspart (Fiasp®) has been accepted by the SMC and added to the Formulary. It is a modified formulation of insulin aspart with the property of more rapid absorption of insulin from subcutaneous injection site than standard...

Read More...

Tiotropium: Braltus Zonda

Posted: June 23, 2017.
Category - Medicines Update
Tagged with - Respiratory

In April 2017, the ADTC accepted the Respiratory MCN’s recommendation on tiotropium inhaler devices. Braltus® Zonda Inhaler is now the preferred brand of tiotropium inhaler. Spiriva Respimat® remains a Total Formulary option. ...

Read More...

Butec (buprenorphine) patch

Posted: June 23, 2017.
Category - Medicines Update
Tagged with - Opioids

Butec® is the NHSGGC preferred brand of buprenorphine 7 day transdermal patch across primary and secondary care. It is restricted to specialist use only in elderly patients (over 65 years) where standard analgesic options are ineffective or...

Read More...

Medicines Update Oncology June 2017

Posted: June 21, 2017.
Category - Medicines Update Oncology

NEW: Guideline for the Management of Immune-related Adverse Events The West of Scotland Cancer Network (WOSCaN) Guidelines for Management of Immune-related Adverse Events have recently been issued by the West of Scotland Cancer Network ...

Read More...